# Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients

> **NCT04437693** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Hamad Medical Corporation** · enrollment: 500 (estimated)

## Conditions studied

- COVID 19

## Interventions

- **DRUG:** Hydroxychloroquine

## Key facts

- **NCT ID:** NCT04437693
- **Lead sponsor:** Hamad Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-31
- **Primary completion:** 2021-08-30
- **Final completion:** 2021-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2020-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04437693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04437693, "Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04437693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*